Merck Canada Inc.
Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
---|---|---|
Communicate with BC government about conditions under which innovative drugs, vaccines or other therapies are, or could be, reimbursed or otherwise funded publicly in BC, as well as to raise awareness about such topics.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
Communicate with BC government about conditions under which innovative drugs, vaccines or other therapies are, or could be, reimbursed or otherwise funded publicly in BC, as well as to raise awareness about such topics.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Health
|
Explore opportunities for cooperation pertaining to each parties' priorities and interests that may relate to public coverage of medicines, vaccines and services within Canada.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
COVID-19, Health, Hospitals
|
Explore opportunities for cooperation pertaining to each parties' priorities and interests that may relate to public coverage of medicines, vaccines and services within Canada.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19, Health, Hospitals
|